Abstract
Particle radiation therapy using proton or carbon beams is an emerging new treatment modality for skull base tumors such as chordomas, chondrosarcomas, and meningiomas, as well as for photon-resistant malignant brain tumors. Recent advances in beam-delivery systems, research into the biological and molecular mechanism of radiation-induced bystander effect, local tumor recurrence, metastasis, and late radiation injury are all important issues for future development and clinical application of particle radiation therapy.